SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-038141
Filing Date
2024-03-28
Accepted
2024-03-28 16:52:22
Documents
90
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K drrx-20231231.htm   iXBRL 10-K 3565501
2 EX-4.1 drrx-ex4_1.htm EX-4.1 50904
3 EX-23.1 drrx-ex23_1.htm EX-23.1 9113
4 EX-31.1 drrx-ex31_1.htm EX-31.1 13007
5 EX-31.2 drrx-ex31_2.htm EX-31.2 13400
6 EX-32.1 drrx-ex32_1.htm EX-32.1 5741
7 EX-32.2 drrx-ex32_2.htm EX-32.2 5707
8 EX-97.1 drrx-ex97_1.htm EX-97.1 45894
9 GRAPHIC img99891223_0.jpg GRAPHIC 70629
10 GRAPHIC img99891223_1.jpg GRAPHIC 84952
  Complete submission text file 0000950170-24-038141.txt   13910722

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT drrx-20231231.xsd EX-101.SCH 1815321
94 EXTRACTED XBRL INSTANCE DOCUMENT drrx-20231231_htm.xml XML 2443099
Mailing Address 10240 BUBB ROAD CUPERTINO CA 95014
Business Address 10240 BUBB ROAD CUPERTINO CA 95014 4087771417
DURECT CORP (Filer) CIK: 0001082038 (see all company filings)

IRS No.: 943297098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-31615 | Film No.: 24799989
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)